Search
for
Sort by
Research 181–210 of 1000+
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- Novel 5α-Reductase Inhibitors: Synthesis, Structure−Activity Studies, and Pharmacokinetic Profile of Phenoxybenzoylphenyl Acetic Acids
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients
- Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
- The 5α-reductase inhibitor finasteride reduces opioid self-administration in animal models of opioid use disorder
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- Plants as potential active components in treatment of androgenetic alopecia
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III
- Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide
- Steroid Hormones
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Androgenetic Alopecia Treated With Topical Minoxidil. A Case Report and Review of Treatment Options
- Hormone Blocking Anticancer Drugs
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Abstracts
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- ALOPECIA ANDROGENÉTICA: DIAGNÓSTICO, TERAPIAS CLÍNICAS E PROCEDIMENTOS ESTÉTICOS
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Screening of Tyrosinase, Xanthine Oxidase, and α-Glucosidase Inhibitors from Polygoni Cuspidati Rhizoma et Radix by Ultrafiltration and HPLC Analysis
- HaCaT‑conditioned medium supplemented with the small molecule inhibitors SB431542 and CHIR99021 and the growth factor PDGF‑AA prevents the dedifferentiation of dermal papilla cells <i>in vitro</i>